Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin in short bowel syndrome
NCT02653131Phase 4Terminated
- Sponsor
- Stanley Dudrick Memorial Hospital
- Start
- Jan 2016
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in short bowel syndrome (SBS), sponsored by Stanley Dudrick Memorial Hospital. Started Jan 2016; status: terminated.
02
Drugs
sitagliptin
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT02653131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653131.